Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

50.04 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 000000-215.0790215.079318.852190.013135.7492.93343.82317.6649.6981.15100000000000
Kosten van de omzet 0.9770.9410.9480.8570.80.76435.7410.3770.45626.34235.94925.51417.33912.8624.2443.0580.42400000000000
Brutowinst -0.977-0.941-0.948-0.857-0.8-0.764-250.82-0.377214.623292.51154.064110.22675.59430.96113.426.640.72700000000000
Brutowinstmarge 0000001.16600.9980.9170.8110.8120.8130.7070.760.6850.63200000000000
Onderzoek- en ontwikkelingskosten 314.819155.972134.81395.51779.4963.461137.04452.845177.08770.09641.81846.97377.428107.11157.04442.42556.0766.01961.674175.97741.00347.36229.05275.57966.75534.99621.01910.74
Algemene en administratieve kosten 18.95327.26818.89815.0314.52114.32176.36814.79220.02319.6779.0658.5199.9159.91500068.9728.78223.23513.4627.5749.0647.85712.5274.5714.1993.757
Verkoop- en marketingkosten -0.977-0.941-0.948000000000160.142149.60800000000000000
Verkoop-, algemene en administratieve kosten 17.97626.32717.9515.0314.52114.32176.36814.79220.02319.6779.0658.519170.057159.523119.533124.80295.60168.9728.78223.23513.4627.5749.0647.85712.5274.5714.1993.757
Overige kosten 14.1784.3057.7434.6865.8428.229-1.8380-0.067-0.0041.454-0.0050000000000000000
Bedrijfskosten 332.795182.299152.763110.54794.01177.782213.41267.637197.1189.77350.88355.492247.485266.634176.577167.227151.671134.98990.456199.21254.46554.93638.11683.43679.28239.56725.21814.497
Bedrijfsresultaat -333.772-183.24-153.711-110.547-94.011-77.782-213.412-67.637-197.11-89.773-50.883-55.492-171.891-235.673-163.157-160.587-150.944-134.989-90.456-199.212-54.465-54.936-38.116-83.43679.282-39.567-25.218-14.497
Bedrijfsresultaat ratio 0000000.9920-0.916-0.282-0.268-0.409-1.85-5.378-9.237-16.559-131.14200000000000
Totaal overige inkomsten en kosten netto 14.1784.3057.7434.6865.8428.229-1.8380-0.067-0.0041.454-0.005-34.918-25.831-29.482-19.689-21.299-14.346-15.388-11.8-7.73-6.344-1.128-1.93920.179-3.293-12.823-4.063
Inkomen voor belasting -319.594-178.935-145.968-105.861-88.169-69.553-215.25-67.637-197.177-89.777-49.429-55.497-206.809-261.504-192.639-180.276-172.243-149.335-105.844-211.012-62.195-61.28-39.244-85.37599.461-42.86-38.041-18.56
Inkomen voor belasting ratio 0000001.0010-0.917-0.282-0.26-0.409-2.225-5.967-10.906-18.589-149.64600000000000
Belastingkosten 0.1770.569-1.212-3.2872.1770.939-14.1431.2166.117.2552.457-1.1324.353.8243.9890.6580.694-0.0710.3230.0580.1090.1610.0250.087-0.6470.0550.3990.193
Nettowinst -319.771-179.504-144.756-102.574-90.346-70.492-201.107-68.853-203.287-97.032-51.886-54.365-210.619-264.968-195.189-180.934-172.937-149.264-106.167-211.07-62.304-61.441-39.269-85.462100.108-42.915-38.44-18.753
Nettowinstmarge 0000000.9350-0.945-0.304-0.273-0.401-2.266-6.046-11.05-18.657-150.24900000000000
WPA (Winst Per Aandeel) -3.64-2.2-1.81-1.5-1.32-1.03-3.3-1.75-5.67-2.71-1.45-1.52-3.23-4.27-3.27-3.08-3.07-0.003-2.04-4.67-1.41-1.53-1.01-2.322.753-1.19-1.48-1.43
Verwaterde WPA -3.64-2.2-1.81-1.5-1.32-1.03-3.3-1.75-5.67-2.71-1.45-1.52-3.23-4.27-3.27-3.08-3.07-0.003-2.04-4.67-1.41-1.53-1.01-2.322.753-1.19-1.48-1.43
EBITDA -332.795-182.299-152.763-110.547-92.18-76.133-213.068-67.26-196.695-89.523-50.198-55.266-171.891-235.673-163.157-160.587-150.944-134.989-90.456-199.212-54.465-54.936-38.116-83.43679.282-39.567-25.218-14.497
EBITDA ratio 0000000.9910-0.915-0.281-0.264-0.407-1.85-5.378-9.237-16.559-131.14200000000000